The synthetic peptide CIGB-300 modulates CK2-dependent signaling pathways affecting the survival and chemoresistance of non-small cell lung cancer cell lines

by Stéfano M. Cirigliano, María I. Díaz Bessone, Damián E. Berardi, Carolina Flumian, Elisa D. Bal de Kier Joffé, Silvio E. Perea, Hernán G. Farina, Laura B. Todaro, Alejandro J. Urtreger
Published 2017-03-01